Adapsyn Bioscience
Making microbes work
Hamilton · Founded 2016
- Headquarters
- Hamilton
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- adapsyn.com
- Last Round
- Venture RoundJan 2018
- Rounds
- 1
About
Adapsyn Bioscience is a chemical bioinformatics company that discovers and develops novel small molecule therapeutics derived from microbes. Using integrated genomics, metabolomics, and AI platforms, Adapsyn identifies microbial strains that produce novel chemistry, predicts compound structures and drug-likeness, and isolates candidates for drug discovery programs in oncology, infectious disease, and immunology. The company was spun out of McMaster University in 2016 and is backed by Pfizer Ventures, Genesys Capital, the Bill & Melinda Gates Foundation, and Evotec.
Summary
Adapsyn Bioscience is an Artificial Intelligence company based in Hamilton, founded in 2016. Its most recent funding was a Venture Round round in Jan 2018. Investors include Genesys Capital.
Funding History
Jan 2018
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Scientific superintelligence platform building autonomous AI labs for life, chemical, and materia...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/adapsyn-bioscience"><img src="https://indexed.vc/api/badge/company/adapsyn-bioscience" alt="Adapsyn Bioscience on Indexed.vc" width="260" height="76" /></a>